Cargando…
Effectiveness of interleukin-17A inhibitors in patients with ankylosing spondylitis: A protocol for systematic review and meta-analysis
Ankylosing spondylitis is a chronic immune-mediated inflammatory arthritis. Interleukin-17A (IL-17A) inhibitors is recognized as a novel therapeutic target for ankylosing spondylitis. However, there is still a lack of high-quality research evidence regarding the issues. Therefore, we performed a pro...
Autores principales: | Yan, Mingguang, Fang, Xiao, Guo, Jianjun, Yin, Weibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750646/ https://www.ncbi.nlm.nih.gov/pubmed/36626473 http://dx.doi.org/10.1097/MD.0000000000032224 |
Ejemplares similares
-
Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020) -
The treatment strategies for spine fractures in patients with ankylosing spondylitis: A case report
por: Zhu, RuSen, et al.
Publicado: (2017) -
Surgical Therapy of Cervical Spine Fracture in Patients With Ankylosing Spondylitis
por: Ma, Jun, et al.
Publicado: (2015) -
Analysis of the outcome of bi-vertebral transpedicular wedge osteotomy for correcting severe kyphotic deformity in ankylosing spondylitis
por: Li, Wei, et al.
Publicado: (2023) -
Video-assisted thoracoscopic surgery for Andersson lesion in ankylosing spondylitis: A case report and literature review
por: Dong, Wei-Xin, et al.
Publicado: (2023)